The ACA is moving people with HIV into Medicaid and commercial health plans. Disruption of care can be bad news for people with HIV and for payers.
The former national health technology ‘czar’ says that as insurers’ business models change, information systems will be critical to success
Other nations use ‘quality-adjusted life-years’ to measure the cost-effectiveness of drugs, but this tool has been anathema in the United States — so far
Genomic profiling in cancer may open the door to the use of unproven therapies
Argument about safety reflects biosimilars and brands jockeying for market share
Comprehensive medication management may improve outcomes in medical homes